Charles River Laboratories, Inc., commonly referred to as Charles River, is a leading global provider of preclinical and clinical laboratory services. Headquartered in the United States, the company operates extensively across North America, Europe, and Asia, serving a diverse clientele in the pharmaceutical, biotechnology, and medical device industries. Founded in 1947, Charles River has achieved significant milestones, including the expansion of its service offerings and strategic acquisitions that enhance its market position. The company specialises in a range of services, including drug discovery, safety assessment, and laboratory animal medicine, distinguished by its commitment to quality and innovation. With a strong reputation for scientific excellence, Charles River is recognised for its contributions to advancing healthcare and improving patient outcomes, solidifying its status as a trusted partner in the life sciences sector.
How does Charles River Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Charles River Laboratories, Inc.'s score of 62 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Charles River Laboratories, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Charles River Laboratories International, Inc., which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges from Charles River Laboratories, Inc. However, emissions data and climate initiatives may be inherited from its parent company, Charles River Laboratories International, Inc. This includes participation in various sustainability initiatives such as the Science Based Targets initiative (SBTi), CDP, and RE100, all of which are cascaded from the parent organisation. While specific emissions figures are not provided, the company's involvement in these initiatives suggests a commitment to addressing climate change and reducing carbon footprints in alignment with industry standards. Further details on their climate strategy and performance may be available through the parent company's disclosures.
Access structured emissions data, company-specific emission factors, and source documents
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Scope 1 | 86,284,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 79,271,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Charles River Laboratories, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.